Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Cancer Research 2023, UK Cancer Science 2023, Switzerland World Cancer-2023, Switzerland Euro Cancer 2023, France

Asia Pacific & Middle East

Business Management 2023, India Cancer Care 2023, Malaysia Oral Health 2023, Malaysia Vaccine Immunology 2023, Japan

Canada

Virology-2023, Canada Heart Congress-2023, Canada

Oncology 2023

About Conference

Conferenceseries Ltd welcomes everyone all over the world to participate in the “4^th Global Summit on Oncology and Hematology” during March 27-28, 2023 London, UK.

Oncology 2023 coordinates towards tending to main issues as well as future strategies of Cancer. This will be the biggest and most encouraging universal gathering where the program incorporates Clinical Oncologists, Registered Nurses, Nurse specialists and the whole restorative group required in patient care, scientists, proficient, early profession people who wish to learn standards of tumour immunology and immunotherapy well as leaders will come to examine on different parts of challenges, risks and investment opportunities of Cancers. Global Cancer at Singapore will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Global Cancer will also provide the three days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumour, leukaemia, blood cancer, cervical tumour, colon-rectum disease, pediatric malignancy, surgical tumour, Prostate growth, thyroid malignancy.

ConferenceSeries llc LTD which contains 3000+ Global Events with more than 600+ Conferences, 1200+ Symposiums and 1200+Workshops on assorted Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is arranging meetings everywhere throughout the globe. Conferenceseries LLC has various Cancer Gatherings, Cancer meeting, worldwide growth gathering, European Oncology Conferences, Surgical oncology like skin tumour gathering, bosom malignancy meeting, liver malignancy gathering, Lung Cancer gatherings, and Oncology Conferences where learning exchange happens through civil arguments, round table discourses, notice introductions, workshops, symposia and presentations and which gets potential outcomes for treating the maladies with new time, innovation and research.

Who and Why??

ONCOLOGY RESEARCH 2023 Conference brings together the specialists from all the aspects to discuss about the future of Oncology and Cancer in today’s world to thrive and survive with a better health. Directors specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies and all other interested participants willing to enhance and update the knowledge may attend the conference.

Cancer Science & Oncology:

The branch of health care that determines the safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed Clinical Research .These are used for the treatment , prevention, diagnosis and relieving symptoms of the diseases. Clinical research may differ from clinical practice. Clinical Practice uses established process , whereas in case of clinical research evidence is collected for establishing the new treatment using “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.

Sessions & Tracks

Track 1: Cancer Stem Cell

Cancer Stem Cell (CSC) hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with expanded tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 2: Oncology Research

Oncology is a part of the medication that bargains with the anticipation, conclusion, and treatment of Cancer disease. Survival has been enhanced because of three primary segments including enhanced counteractive action endeavours to diminish presentation to chance elements (e.g., tobacco smoking and liquor utilization) enhanced screening of a few tumours (taking into consideration prior finding), and upgrades in treatment.

Malignant growths are regularly overseen through discourse on multi-disciplinary disease gatherings where radiation oncologists, pathologists, radiologists, and organ particular oncologists meet to locate the most ideal administration for an individual patient considering the physical, social, mental, and money related status of the patient. It is vital for oncologists to keep refreshed as for the most recent headways in oncology, as changes in administration of malignancy are very normal.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 3: Oncology Research Categories

Cancer Oncology examines are being led remembering different classes or criteria like area, influenced organ, sort of Cancer disease, kind of consideration or drug, condition or encompassing.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 4: Stem cells

Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 5: Bio-markers of Cancer Stem Cells

Liver cancer is the fifth most analysed and the second most ceaseless reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours. Research into the molecular biology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have probable predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to represent HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 6: Immunology

Immunology is a part of science that covers the study of immune systems in all living beings. Immunology outlines, measures, and contextualizes the physiological working of the immune system in conditions of both wellbeing and sicknesses; breakdowns of the immune system in immunological disorders , example : autoimmune diseases,, hypersensitivities immune deficiency, and rejection of transplants: the physical, compound and physiological attributes of the segments of the immune system in vitro, in situ, and in vivo. Immunology has applications in various orders of medication, especially in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 7: Cancer Stem Cell Treatments

Cancer treatments against tumour, chemo-and radiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumour formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of CSCs. On-going distinguishing proof of surface markers and comprehension of atomic element is related with CSC phenotype, assisted with the plan of viable medicines

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 8: Types of Cancer

Cancer types include Carcinoma, Sarcoma, tumours got from epithelial cells. This gathering incorporates a large number of the most widely recognized malignancies and incorporate almost each one of those in the bosom, prostate, lung, pancreas and colon.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 9: Nanotechnology in Cancer

Cancer nanotechnology is a part of nanotechnology which deals with various techniques, equipment’s also known as Nano-materials to the analysis and treatment of cancer. It is the branch of nanotechnology that uses Nano-science and Nano vectors to cure or stop cancer cells and their growth

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 10: Cancer Stages

Organizing can be "clinical" or "neurotic." Clinical organizing is based on the after effects of the tests done prior to the medical procedure for example: physical examinations and imaging filters. Neurotic organizing based on what is found through the medical procedure. Clinical stage is regularly demonstrated by a lowercase "c" before the TNM grouping. The obsessive stage is demonstrated by a lowercase "p."

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 11: Cancer Causes

There can be more than one reason for cancer cells formation and growth. Various powers can cause quality changes, for example, smoking, radiation, infections, Cancer causing synthetic compounds (cancer-causing agents), heftiness, hormones, endless aggravation and an absence of activity.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 12: Cancer Treatment

The causes for cancer may differ from genetic to the lifestyle of an individual. Cancer can spread from one region of the body to another and can also lead to death, there are some ways to treat or to reduce the spread of it.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 13: Cancer prevention

Cancer Prevention contains steps that are taken to bring down the danger of getting the Cancer disease. This can incorporate keeping up a solid way of life, to know disease causing substances, and taking prescriptions or immunizations that can keep cancer from formation.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 14: Clinical research and trials in stem cells and cancer

Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 15: Bioinformatics and Systems Biology

Bioinformatics and System Biology utilize PC techniques to investigate the natural information. As opposed to the past attention on single qualities or proteins, frameworks science is a field of research which focuses on understanding whole natural frameworks, for example: protein buildings, metabolic pathways, or quality administrative systems.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 16: 3D Bio printing & Bio fabrication

Bio fabrication is alluded to the generation of fake tissues or organs to address wellbeing challenges in medication. It frequently utilizes the rule of 3D Bio printing to shape cells, gels and strands into an organ.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 17: Gene therapy

Gene Therapy is an exploratory strategy that utilizes qualities to treat or anticipate ailment. Later on, this strategy may enable specialists to treat confusion by embedding a quality into a patient's cells as opposed to utilizing medications or medical procedure. In spite of the fact that gene therapy is a promising treatment alternative for various ailments (counting acquired disarranges, a few sorts of malignancy, and certain viral contaminations), the system stays hazardous is still under examination to ensure that it will be protected and successful. Gene Therapy is as of now being tried just for maladies that have no different fixes

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 18: Stem Cell Biology and advances

Most of the structural microorganisms have the astonishing potential to form into a wide range of cell types, basically unlimited to renew different cells until the individual is alive, offering any expectation of relieving Alzheimer's disease , treating kidney, liver and lung diseases . Until today, researchers principally worked with two types of undistinguishable organisms from creatures and people that are embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem cell with various improvements. The audit will quickly talk about the on-going developments here.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 19: Advances in Tissue Regeneration

Tissue Engineering is a logical field and depicted as understanding the benchmarks of tissue and its improvement by handy exchange of insufficient tissue for clinical use. Tissue building deals about the investigation of mixing of cells, structuring, materials and methodologies, biochemical segments to upgrade characteristic tissues. It includes the utilization of Scaffolds to shape practical tissues and organs, which can be embedded, again into the benefactor, have with the utilization of many building and materials techniques alongside some hemispherical elements. It is recognized with in excess of one branch which applies building information and life science ideas towards the advancement of natural substitutes which can enhance or re-establish all the qualities of an organ.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 20: Umbilical Cord Stem Cells

Moral and logical issues encompass both embryonic and fatal Cord Stem cells and frustrate their across the board usage. Interestingly, foundation microorganisms recuperated postnatal from the umbilical line, including the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest wellspring of cells that are fit for framing a wide range of cell types (i.e., they are "multi-potent"). This survey will centre around the umbilical rope determined immature microorganisms and contrast those cells and grown-up bone marrow-inferred melancholy undifferentiated organisms.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 21: Stem Cell and Tissue Homeostasis

Tissue homeostasis depends upon the precise direction of substantial foundational microorganism movement. Substantial undeveloped cells need to react to tissue and therefore harm and multiply as per tissue requirements, while staying away from over-multiplication. The administrative systems engaged with these reactions are presently being separated in the intestinal epithelium of Philosophical, giving new understanding into procedures and components of undeveloped cell direction in obstruction epithelial.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 22: Stem Cell Aging

Maturing tissues encounter a dynamic decrease in homeostatic and regenerative limits, which has been credited to degenerative changes in tissue-particular foundation microorganisms, undifferentiated organism specialties and fundamental signals that manage undeveloped cell action. Understanding the sub-atomic pathways associated with this age-subordinate crumbling of immature microorganism capacity will be basic for growing new treatments for maladies of maturing that objective the particular reasons for age-related utilitarian decay. Here we investigate key sub-atomic pathways that are generally irritated as tissues and undifferentiated organisms age and savage.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 23: Stem Cell Therapy

Essential microorganisms are the body's rough materials cells from which each other cell with particular boundaries are created. New stem cells either end up being new undifferentiated cells with a more specific limit for instance: platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the featured ability to make new cell types.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 24: Recent advances in Stem Cell

All the immature microorganisms possess an amazing potential to form into various cell types, basically unbounded to renew different cells as long as the individual is alive, thus offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung sicknesses. Until today, researchers essentially worked with two sorts of undeveloped cells from creatures and people: embryonic undifferentiated cells and non-embryonic "substantial" micro-organisms. On-going achievement makes it conceivable to change over or "re-invent" specific grown-up cells to expect stem-like cells with various advancements. The survey will quickly talk about the on-going advances here.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 25: Epidermal Stem Cells

The skin continually re-establishes itself for the duration of grown-up life, and the hair follicle experiences an interminable cycle of development and degeneration. Microorganisms (Stem cells) dwelling in the epidermis and hair follicle guarantee the support of grown-up skin homeostasis and hair recovery, however they likewise take part in the fixation of the epidermis after wounds.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 26: Stem Cell Renewal

In numerous tissues, mammalian maturing is linked with a decrease in the replicative and effective limit of physical immature microorganisms and other self-recharging compartments. Therefore understanding the premise of this decay is a noteworthy objective of maturing research. . Such methodologies incorporate accomplishments to shield undifferentiated organisms from age-advancing harm, to 'revive' foundation microorganisms using pharmacologic specialists that moderate maturing impelled modifications in flagging, and to replace lost undeveloped cells through regenerative drug approaches. Some progress has been made in every one of these fields in the course of the most recent year and a half incorporating advances in the generation of contributor particular supreme undifferentiated organisms through prompted diplomat, gains in our command of how tumour silencer flagging is controlled in self-restoring compartments to direct maturing, and further show of extracellular 'milieu' factors that bother undeveloped cell work with age.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 27: Ethics considerations in stem cell therapy

Stem Cell Research offers incredible guarantee for understanding fundamental elements of human advancement and separation, additionally the expectation for new medications for illnesses, for example, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In any case, human Stem Cell inquires about additionally raises sharp moral and political contentions. The reconstructing of substantial cells to deliver instigated pluripotent undifferentiated organisms keeps away from the moral issues particular to embryonic microorganism examine. In any hSC look into, be that as it may, troublesome problems emerge with respect to delicate downstream research, agree to give materials for hSC explore, early clinical preliminaries of hSC treatments, and oversight of hSC inquire about. These moral and strategy issues should be talked about alongside logical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic investigation of these issues and how they are tended to in current approaches

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 28: Advances in developmental biology and stem cells

Developmental biology is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, transformative components, neurobiology, and frameworks science has its heritage in formative science. Formative science keeps on moving on, while holding its very own character. While its relative controls separate into sciences with a limited arrangement of standards, precedents, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the developmental point of view is being reaffirmed as a critical research program.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 29: DNA Damage, Mutation and Cancer

A huge number of chemicals and several physical agents, such as UV light and γ-radiation, have been related with the etiology of human cancer. Causing of DNA damage brought by these agents is an essential first step in the process of carcinogenesis. Evolutionary processes gave rise to DNA repair tools that are capable in repairing damaged DNA; yet replication of damaged DNA may take place prior to repair, particularly when they are induced at a high frequency. Damaged DNA replication may cause gene mutations, that may give rise to altered proteins.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Track 30: MicroRNAs and cancer

MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs.

EUROPEAN SOCIETIES

ASIAN SOCIETIES

AMERICAN SOCIETIES

Market Analysis

Note: Global Cancer will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children

Market Analysis:

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.

Importance and Scope:

2019 Global Cancer will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children.

North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2015, shadowed by Europe which accounted for around 29.1% share in the market.

Major Cancer Associations:

Worldwide:

American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumor Association
American Society of Pediatric Hematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre

In Asia Pacific:

Medical Excellence JAPAN
Japan Community Health care Organization Chukyo Hospital
Aichi Cancer Center Hospital
Japanese Red Cross Nagoya Daiichi Hospital
Kyoto University Hospital
Dokkyo Medical University Hospital
Japan Hospital Association
Aizawa Hospital

Major Medical Universities:

Worldwide:

Emory University
Karolinska University
University of Cambridge
University of Oxford Stanford University
UNC School of Medicine
Harvard University
Mayo Medical School
Yale University
University of Minnesota
John Hopkins University
Pittsburgh School of Medicine
University of Wisconsin
Kings College London
Feinberg School of Medicine

In Asia Pacific:

The University of Tokyo
University of Delhi
KAIST - Korea Advanced Institute of Science and Technology
National University of Singapore (NUS)
Kyoto University
University of Hong Kong (HKU)
Peking University
Seoul National University (SNU)
National Taiwan University (NTU)
Osaka University
Tsinghua University0
The Chinese University of Hong Kong (CUHK)
Fudan University
The Hong Kong University of Science and Technology (HKUST)
Shanghai Jiao Tong University
Mahidol University
Korea University
Beijing University of Chinese Medicine
Taipei Medical University
Beijing Institute of Technology
Yonsei University
Nanyang Technological University (NTU)
Chulalongkorn University
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan University
University of Science and Technology of China
Pohang University of Science and Technology (POSTECH)
Universiti Malaya (UM)
Zhejiang University
Keio University
Indian Institute of Science
Tokyo Institute of Technology
Universiti Kebangsaan Malaysia (UKM)
Universiti Sains Malaysia (USM)
Nanjing University
Kyung Hee University
National Yang Ming University
University of Indonesia
University of the Philippines
University of Tsukuba
Bandung Institute of Technology (ITB)
Hanyang University
Indian Institute of Technology Bombay (IITB)
National Cheng Kung University
Universiti Putra Malaysia (UPM)

Target Audience: Oncologists, Radiologists, Immunologists, Clinical Researchers, Doctors, Researchers, Youthful Researchers, Undergraduates, Business Entrepreneurs, Brand Manufacturers/ Marketers of Consumer Products, Pharmaceutical Companies and Diagnostics Companies

Past Report

Oncology 2022 marked with the attendance of honourable keynote speaker, Honourable guests, delegates, Physician, Academic researchers, Organizing Committee Members, Physicians, and talented student communities representing more than 20 countries, who made this conference a remarkable and productive.

This Global Summit on Healthcare & Technologies was based on the theme “Advancements and Emerging Concepts in Oncology and Hematology Research” which has covered the below scientific sessions:

Biomarkers in Hematology and Oncology
Hematology & Oncology Nursing
Cancer: Lifestyle and Nutrition
Cancer Immunology & Immunotherapy
Hematology and Pharma Industry
Hormonal Therapy
Key Role of Pathology in Cancer
Cancer & Stem Cell Therapy
Cancer Nanotechnology
Cancer Chemotherapy
Neonatal and Pediatric Oncology
Ovarian Cancer
Oral Oncology
Gynecology, Infectious Diseases and Oncology

The conference was initiated with a series of lectures delivered by both Honourable Guests and members of the Keynote forum.

With the grand success of Oncology- 2022, Conferenceseries LLC Ltd is proud to announce the " 4^th Global Summit on Oncology and Hematology” March 27-28, 2023 London, UK.

Let us meet again : https://oncology.cancersummit.org/

To Collaborate Scientific Professionals around the World

Conference Date March 27-28, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Oncology 2020 Conference

Supported By

Archives in Cancer Research Journal of Cancer Science & Therapy Journal of Integrative Oncology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Oncology and Hematology

March 27-28, 2023 London, UK

Exploring the Research Challenges & Advancements in Oncology and Therapeutic Strategies

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Oncology 2023

About Conference

Sessions & Tracks

Market Analysis

Past Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Keytopics